PHI

State Collection Service Achieves HITRUST Risk-Based, 2-year Certification Demonstrating the Highest Level of Information Protection Assurance

Retrieved on: 
Monday, April 22, 2024
Certification, State, Risk management, PHI, HITRUST, Privacy, Organization, Medical device

MADISON, Wis., April 22, 2024 /PRNewswire-PRWeb/ -- State Collection Service, a leading provider of healthcare receivables management, today announced that its collection software systems, servers, workstations, and physical offices have earned certified status by HITRUST for information security.

Key Points: 
  • HITRUST Risk-Based, 2-year (r2) Certification validates State Collection Service is committed to strong cybersecurity and protecting sensitive data.
  • "State continually strives to appropriately protect PHI by addressing current and emerging threats while meeting complex compliance, information protection, and privacy requirements," said Jim Warner, chief technology and security officer at State.
  • "We are pleased to demonstrate to our customers the highest data protection and information security standards by achieving the rigorous HITRUST r2 Certification."
  • "HITRUST r2 Certification demonstrates State is taking the most proactive approach to cybersecurity, data protection, and risk management."

Kind Pharmaceuticals Announces Settlement

Retrieved on: 
Tuesday, April 16, 2024
PHI, CKD, Clinical trial, Patient, Anemia, Chronic kidney disease, Pharmaceutical industry

HANGZHOU, China, April 16, 2024 /PRNewswire/ -- Today, Hangzhou Andao Pharmaceutical Ltd. and Kind Pharmaceuticals LLC ("Kind Pharmaceuticals"), together with its Chief Executive Officer Dr. Dong Liu and Chief Scientific Officer Dr. Shaojiang Deng, announced a resolution of their recent dispute with FibroGen, Inc. regarding Kind Pharmaceuticals' hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF- PHI) technology.

Key Points: 
  • HANGZHOU, China, April 16, 2024 /PRNewswire/ -- Today, Hangzhou Andao Pharmaceutical Ltd. and Kind Pharmaceuticals LLC ("Kind Pharmaceuticals"), together with its Chief Executive Officer Dr. Dong Liu and Chief Scientific Officer Dr. Shaojiang Deng, announced a resolution of their recent dispute with FibroGen, Inc. regarding Kind Pharmaceuticals' hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF- PHI) technology.
  • Kind Pharmaceuticals' HIF-PHI drug candidate, AND017, is currently being studied in a clinical trial for the treatment of anemia in chronic kidney disease (CKD) patients.
  • As a result of the settlement, Kind Pharmaceuticals remains free to develop AND017 and other HIF-PHIs in its pipeline.
  • Dr. Liu, Chief Executive Officer of Kind, commented: "Kind is pleased that these disputes have been fully and finally resolved.

DoControl Integrates Google Workspace Labels to Protect Sensitive Data Across My Drive and Shared Drive

Retrieved on: 
Wednesday, April 10, 2024
Salesforce, Metadata, Label, PII, SharePoint, Communication, Software as a service, PCI, OneDrive, Google Workspace, Entrepreneurship, Vault, DLP, PHI, Box, Google Drive, Satellite navigation device

NEW YORK, April 10, 2024 /PRNewswire/ -- DoControl, a leading provider of SaaS Security solutions, announces its integration with Google Workspace Labels, to discover, understand, and protect sensitive data in Google Drive. The integration catalogs Google DLP, Vault, and Self-Service Labels across My Drive and Shared Drive. This aggregation of Google Labels, HRIS/IDP metadata, and end-user activity gives DoControl the context needed to protect sensitive data, mitigate insider threats, and stop data breaches. 

Key Points: 
  • The aggregation of Google Labels, HRIS/IDP metadata, and end-user activity provides DoControl with the context needed to stop data breaches
    NEW YORK, April 10, 2024 /PRNewswire/ -- DoControl , a leading provider of SaaS Security solutions, announces its integration with Google Workspace Labels, to discover, understand, and protect sensitive data in Google Drive.
  • This aggregation of Google Labels, HRIS/IDP metadata, and end-user activity gives DoControl the context needed to protect sensitive data, mitigate insider threats, and stop data breaches.
  • For security teams, Google Labels help discover sensitive data across My Drive and Shared Drive.
  • By integrating Google Labels findings, DoControl helps Google Workspace customers isolate sensitive data and prevent its exposure to unauthorized personnel from within or outside the company.

Vestaron and Simplot Grower Solutions Forge Strategic Distribution Partnership to Deliver Novel Sustainable Solutions for Farmers

Retrieved on: 
Wednesday, March 27, 2024
LEP, Farmer, SPEAR, Face, PHI, Vegetable, Partnership, Agriculture, Biodiversity, Marketing, MRL, Product management, IPM, Insecticide, REI

This strategic collaboration brings together Vestaron's novel insecticides and Simplot Grower Solutions’ extensive network and agronomic expertise, to deliver sustainable and effective crop protection solutions to farmers across the country.

Key Points: 
  • This strategic collaboration brings together Vestaron's novel insecticides and Simplot Grower Solutions’ extensive network and agronomic expertise, to deliver sustainable and effective crop protection solutions to farmers across the country.
  • By joining forces with Vestaron, Simplot Grower Solutions aims to enhance its portfolio of sustainable solutions, providing farmers with access to cutting-edge technologies that contribute to both productivity and environmental stewardship.
  • Dean Williams, Head of Product Management for Simplot Grower Solutions, commented, “Simplot is proud to partner with Vestaron in our aligned commitment to deliver the leading biological crop protection solutions our farmer customers require.
  • Nationwide Reach: Simplot Grower Solutions’ widespread network will ensure that SPEAR LEP insecticide will reach farmers across the United States, promoting accessibility and adoption.

Federman & Sherwood Investigates Group Health Cooperative of South Central WI for Data Breach

Retrieved on: 
Tuesday, April 9, 2024
Class Action Lawsuit, Professional Services, Legal, PHI, Address, Medicare, Federman, Information technology, Medicaid, Death

The law firm of Federman & Sherwood has initiated an investigation into Group Health Cooperative of South Central WI with respect to their recent data breach.

Key Points: 
  • The law firm of Federman & Sherwood has initiated an investigation into Group Health Cooperative of South Central WI with respect to their recent data breach.
  • On January 25, 2024, Group Health Cooperative of South Central WI identified unauthorized access to its network.
  • The attacker attempted to encrypt Group Health Cooperative of South Central WI’s system but was unsuccessful.
  • On February 9, 2024, during its investigation, Group Health Cooperative of South Central WI discovered indications that the attacker had copied some of Group Health Cooperative of South Central WI’s data, which included protected health information (PHI).

Notice of Cybersecurity Incident at GHC-SCW Involving Personal Health Information

Retrieved on: 
Tuesday, April 9, 2024
CISA, PHI, Address, Risk, Information technology, Death, State bureau of investigation, Privacy, Medicaid, FBI, Medicare, Federal Trade Commission, Medical device

Unfortunately, this notice is to inform individuals of a recent security incident that impacted their personal information.

Key Points: 
  • Unfortunately, this notice is to inform individuals of a recent security incident that impacted their personal information.
  • Their Information Technology (IT) Department purposefully isolated and secured their network, causing several of their systems to be temporarily unavailable.
  • On February 9, 2024, during their investigation, they discovered indications that the attacker had copied some of GHC-SCW's data, which included protected health information (PHI).
  • For additional guidance on steps to take to protect your personal information please visit ghcscw.com/cybersecurity/ or contact the Federal Trade Commission at www.ftc.gov or (877) 438-4338.

Vestaron Granted Registration of BASIN™ Bioinsecticide Active Ingredient in Mexico

Retrieved on: 
Thursday, March 21, 2024
Farmer, PHI, EPA, Trade Wars, MRL, Interim, Pest control, Marketing, Agriculture

Durham, North Carolina, March 21, 2024 (GLOBE NEWSWIRE) -- Vestaron Corporation, a leading provider of environmentally-friendly agricultural crop protection solutions, is proud to announce that COFEPRIS (Federal Commission for Protection against Sanitary Risk) has granted registration of the active ingredient of BASIN insecticide in Mexico.

Key Points: 
  • Durham, North Carolina, March 21, 2024 (GLOBE NEWSWIRE) -- Vestaron Corporation, a leading provider of environmentally-friendly agricultural crop protection solutions, is proud to announce that COFEPRIS (Federal Commission for Protection against Sanitary Risk) has granted registration of the active ingredient of BASIN insecticide in Mexico.
  • This significant achievement comes just two weeks after the United States Environmental Protection Agency (EPA) granted unconditional registration for BASIN insecticide in the United States.
  • With the approval of this active ingredient, Vestaron anticipates a commercial launch of BASIN in or before 2025.
  • “The registration of BASIN insecticide by COFEPRIS underscores our commitment to delivering innovative solutions that benefit both farmers and the environment.”
    The approval of BASIN insecticide in Mexico represents Vestaron Corporation's second active ingredient to receive full regulatory approval outside of the United States.

Lexbe Unveils AutoPilot: Revolutionary GenAI-Powered Automated Document Review

Retrieved on: 
Tuesday, March 19, 2024
Automation, Synthetic media, Entrepreneurship, PHI, Risk, Autopilot, Warner Bros. Discovery EMEA, Research, PII, ESI, TAR, Human, CAL, Generative, Medical device

AUSTIN, Texas, March 19, 2024 (GLOBE NEWSWIRE) -- Lexbe , a leading provider of generative artificial intelligence (GenAI) powered eDiscovery solutions, is proud to announce the launch of Lexbe AutoPilot , an innovative GenAI-powered automated document review solution designed to revolutionize the document review process for responsiveness, privilege, and other key legal classification and summarization.

Key Points: 
  • AUSTIN, Texas, March 19, 2024 (GLOBE NEWSWIRE) -- Lexbe , a leading provider of generative artificial intelligence (GenAI) powered eDiscovery solutions, is proud to announce the launch of Lexbe AutoPilot , an innovative GenAI-powered automated document review solution designed to revolutionize the document review process for responsiveness, privilege, and other key legal classification and summarization.
  • Lexbe AutoPilot can be used as an effective ‘first pass review’ to make a matter ready for review by human reviewers within law firms or in contract managed review firms.
  • Also, Lexbe AutoPilot can be combined with state-of-the-art statistical sampling to classify and produce responsive documents with manual human review limited to quality control.
  • AutoPilot harnesses the power of Generative AI to transform how legal professionals handle document review.

Tidepool Achieves SOC 2 Type II Compliance

Retrieved on: 
Friday, April 5, 2024
Software, Health, Diabetes, Data Management, Health Technology, Technology, Other Technology, Security, Single sign-on, SOC, AICPA, CSA, Attention, Risk management, PHI, GDPR, CCPA, NIST, HIPAA, American Institute, SAAS, PCI, SSO, EHR, SOC 2, ISO, Data management, Certified Public Accountant, Audit

Tidepool, a software company committed to innovations in diabetes management, is thrilled to announce the achievement of SOC 2 Type II compliance in accordance with American Institute of Certified Public Accountants (AICPA) standards for SOC for Service Organizations also known as SSAE 18.

Key Points: 
  • Tidepool, a software company committed to innovations in diabetes management, is thrilled to announce the achievement of SOC 2 Type II compliance in accordance with American Institute of Certified Public Accountants (AICPA) standards for SOC for Service Organizations also known as SSAE 18.
  • Achieving this standard with an unqualified opinion serves as third-party industry validation that Tidepool provides enterprise-level security for customers’ data secured in the Tidepool Data Platform.
  • “With this attestation, we are confirming our ongoing commitment to the compliance standards reflected in achieving and maintaining SOC 2 Type II compliance,” says Ben Derr, Lead Security Engineer at Tidepool.
  • An unqualified opinion on an SOC 2 Type II audit report demonstrates to Tidepool’s current and future customers that they manage their data with the highest standard of security and compliance.

NTT Research PHI Lab Scientists Achieve Quantum Control of Excitons in 2D Semiconductors

Retrieved on: 
Tuesday, March 26, 2024
Semiconductor, Technology, Nanotechnology, Telecommunications, Other Science, Research, Science, ETH Zurich, Photon, Physics, University of Notre Dame, Logic, 2D, CMOS, Quantum, PHI, MIT, Cornell University, Ames Research Center, Swinburne University of Technology, Light, University, Nature, Nobel Prize, Architecture, Silicon, NASA, Harvard University, NTT, Stanford University, CIM, Ising, Quantum dot, Engineering, Microscope

NTT Research, Inc. , a division of NTT (TYO:9432), today announced that scientists from its Physics & Informatics (PHI) Lab have achieved quantum control of exciton wavefunctions in two-dimensional (2D) semiconductors.

Key Points: 
  • NTT Research, Inc. , a division of NTT (TYO:9432), today announced that scientists from its Physics & Informatics (PHI) Lab have achieved quantum control of exciton wavefunctions in two-dimensional (2D) semiconductors.
  • However, achieving fine control over their quantum mechanical state has been plagued with scalability issues due to limitations in existing fabrication techniques.
  • In particular, the control over position and energy of quantum dots has been a major hindrance to scaling up towards quantum applications.
  • The PHI Lab has also entered a joint research agreement with the NASA Ames Research Center in Silicon Valley.